Alzheimer's

Biotech

Eisai rebuts report that Alzheimer's med contributed to death

A New England Journal of Medicine entry highlights a potential risk for patients taking Eisai's Alzheimer's med lecanemab.
Annalee Armstrong Jan 4, 2023 5:33pm

Japan greenlights Sysmex's amyloid blood test for Alzheimer's

Dec 22, 2022 10:30am

Janssen moves 1 of 2 AC Immune Alzheimer's vaccines to next step

Nov 30, 2022 10:40am

Lilly powers through final stretch in critical Alzheimer's race

Nov 1, 2022 12:10pm

Lecanemab may have contributed to patient death: report

Oct 28, 2022 10:42am

Biogen's lecanemab commercialization role 'not yet determined'

Oct 25, 2022 11:10am